FDA OKs Odevixibat for Pruritus Associated With Rare Liver Disease ...Middle East

Medscape - News
Odevixibat (Bylvay) is the first drug approved for the treatment of severe itching in children as young as 3 months with progressive familial intrahepatic cholestasis. FDA Approvals

Hence then, the article about fda oks odevixibat for pruritus associated with rare liver disease was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs Odevixibat for Pruritus Associated With Rare Liver Disease )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News